CB2R activation enhances tumor-associated macrophages-mediated phagocytosis of glioma cell
2024

CB2R Activation Enhances Phagocytosis of Glioma Cells by Macrophages

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): Siyuan Lu, Xuezhu Chen, Yang Yang, Junlong Li

Primary Institution: Third Military Medical University

Hypothesis

The study aimed to investigate the effect and mechanism of endocannabinoid receptor 2 (CB2R) on tumor-associated macrophages (TAMs)-mediated phagocytosis in glioma.

Conclusion

CB2R activation promotes TAMs-mediated phagocytosis of tumor cells by enhancing CD36 expression, suggesting that JWH133 could improve chemotherapy efficacy against glioblastoma.

Supporting Evidence

  • JWH133 significantly boosted TAMs-mediated phagocytosis compared to the control group.
  • AM630 significantly inhibited TAMs-mediated phagocytosis compared to the control group.
  • CB2R activation increased CD36 expression in TAMs, enhancing their phagocytic activity.
  • JWH133 improved the efficacy of temozolomide in inhibiting GBM growth.

Takeaway

This study found that a substance called JWH133 helps immune cells called macrophages eat cancer cells better, which could make cancer treatments work better.

Methodology

The study used immunofluorescence, flow cytometry, and bioluminescent imaging to measure phagocytic activity and tumor growth in xenografted mice.

Limitations

The study did not differentiate between brain-resident microglia and peripheral monocyte-derived macrophages, and the mechanisms of CD36 upregulation need further investigation.

Participant Demographics

Male C57BL/6 mice, aged 4–6 weeks.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.heliyon.2024.e40806

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication